Announcements Trials

Browse Landscape

Phase

Status

Recruiting 5 Active not recruiting 2 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 6 Glioblastoma 6 Colorectal Neoplasms 6 Breast Neoplasms 6 Neoplasm Metastasis 5 Prostatic Neoplasms 4 Pancreatic Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Multiple Myeloma 3 Leukemia, Myeloid, Acute 3 Glioma 3 Carcinoma, Hepatocellular 3 Triple Negative Breast Neoplasms 2 Solid Tumors 2 Solid Tumor 2 Sarcoma 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Ovarian Neoplasms 2 Osteosarcoma 2 Melanoma 2 Lymphoma, T-Cell 2 Lung Neoplasms 2 Immunoblastic Lymphadenopathy 2 Carcinoma, Renal Cell 2 Carcinoma 2 Brain Neoplasms 2 Biliary Tract Neoplasms 2 Astrocytoma 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1

Interventions

exemestane 1 Tamoxifen 1 Magnetic Resonance Spectroscopy 1 Letrozole 1 Anastrozole 1 Absorptiometry, Photon 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Breast Carcinoma In Situ × 30 days × Clear all

NCT06671912 2026-06-02

LoTam

Alliance for Clinical Trials in Oncology

Phase 3 Suspended

Breast Carcinoma In Situ

Data powered by HemOnc (CC BY 4.0) Colophon ⚡